da Vinci® Lobectomy
(Non-small cell lung cancer)
If your doctor has diagnosed you with lung cancer and recommends surgery to remove a portion or a lobe of your lung, you may be a candidate for minimally invasive da Vinci® Surgery. The procedure to remove a lobe of your lung is known as a lobectomy.
Why da Vinci Surgery?
With the da Vinci System, surgeons operate through a few small incisions between your ribs – similar to other minimally invasive approaches. The da Vinci System features a magnified 3D high-definition vision system and special wristed instruments that bend and rotate far greater than the human wrist. As a result, da Vinci enables your surgeon to operate with enhanced vision, precision, dexterity and control.
As a result of da Vinci technology, da Vinci Lobectomy offers precise removal of cancerous tissue1, as well as the following potential benefits compared to open surgery:
- Lower rate of complications2
- Less blood loss2
- Shorter hospital stay2,3
- Less pain2
- Fewer days with chest tube (used to drain excess fluid from the chest)2
- Improved mental quality of life soon after surgery2
State-of-the-art da Vinci uses the latest in surgical and robotics technologies and is beneficial for performing complex surgery. Your surgeon is 100% in control of the da Vinci System, which translates his or her hand movements into smaller, more precise movements of tiny instruments inside your body. da Vinci – taking surgery beyond the limits of the human hand.
Physicians have used the da Vinci System successfully worldwide in approximately 1.5 million various surgical procedures to date. da Vinci is changing the experience of surgery for people around the world.
Risks & Considerations Related to Lobectomy
Potential risks of any lobectomy procedure, including da Vinci Lobectomy, include:4
- Abnormal heartbeat following surgery
- Bronchopleural fistula (abnormal passageway develops between lung airways and the membranes that line the lungs)
- Blood loss requiring transfusion
- To find a da Vinci surgeon nearest you, use our surgeon locator.
- Kernstine KH, Anderson CA, Falabella A. Robotic lobectomy. Operative techniques in thoracic and cardiovascular surgery, 2008:204.e1- 204.e23.
- Cerfolio RJ, Bryant AS, Skylizard L, Minnich DJ. Results of, and technical advancements to, completely portal robotic pulmonary resection using 4 arms (CPRL-4). Submitted to JTCVS April 2011.
- Veronesi G, Galetta D, Maisonneuve P, Melfi F, Schmid RA, Borri A, Vannucci F, Spaggiari L. Four-arm robotic lobectomy for the treatment of early-stage lung cancer. J Thorac Cardiovasc Surg, 2010;140(1):19-25.
- Dylewski MR, Ohaeto AC, Pereira JF. Pulmonary resection using a total endoscopic robotic video-assisted approach. Semin Thorac Cardiovasc Surg. 2011 Spring;23(1):36-42. doi: 10.1053/j.semtcvs.2011.01.005.
The friable nature of pulmonary tissue enhances the risk of vascular, bronchiolar, or other injury that will be difficult to control when using this device. Published clinical experience, as well as clinical studies performed to support this marketing clearance have demonstrated that even surgeons considered expert in laparoscopy/thoracoscopy have substantial learning curves of 10 to 12 cases.
Important Safety Information
Serious complications may occur in any surgery, including da Vinci® Surgery, up to and including death. Individual surgical results may vary. Patients should talk to their doctor to decide if da Vinci Surgery is right for them. Patients and doctors should review all available information on non-surgical and surgical options in order to make an informed decision. Please also refer to http://www.daVinciSurgery.com/Safety for Important Safety Information.
When Is Single-Site Technology Used and What Are the Risks?
da Vinci Surgery with Single-Site® Instruments is cleared for use in gallbladder removal, and for hysterectomy and ovary removal for benign conditions. Patients who are not candidates for non-robotic minimally invasive surgery are also not candidates for da Vinci Surgery, including da Vinci Surgery with Single-Site Instruments. There may be an increased risk of incision-site hernia with single-incision surgery, including Single-Site surgery with the da Vinci System. Single-Site® Instruments for the da Vinci® Si™ System bear the CE mark. This device is cleared for commercial distribution in the U.S. for laparoscopic cholecystectomy, and for hysterectomy and salpingo-oophorectomy for benign conditions.
© 2015 Intuitive Surgical, Inc. All rights reserved. Product names are trademarks or registered trademarks of their respective holders.